Sri Lanka’s government has increased the price of several pharmaceutical products that are in short supply by 40%, as the country’s healthcare system is crippled by the on-going economic crisis in the country.
BIMA, an insurance and telehealth platform working in nine emerging markets, has raised $30m to increase penetration in those markets. It already has 35m insurance policies and has run 2m teleconsultations. HBI speaks to CEO and founder Gustaf Agartson.
The new CEO of IHH Healthcare is considering divesting some assets as he shifts strategy to focus on geographical clusters. Which of its 80 hospitals could face the block? HBI examines.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Government regulations mean hospitals have been forced to cut their charges for drugs and devices in that cardiology and orthopaedics. Pacemakers are to be hit next, with falls of 50-70% in pricing. These price cuts apply even for wealthy private patients paying cash. Small wonder the largest player, Apollo Hospitals, is down 29% on the year with Fortis off 18%. So how are Indian hospital groups reacting?
The Sri Lankan healthcare market is growing at breakneck speed says director of Hemas Hospitals, Murtaza Esufally. Problems with the public system are driving patients towards the private sector.
Globalization—whether you like it or not—has been the major force shaping markets for industrial goods for the past century. Until recently, services, including health services, were largely domestic businesses operating in national markets. Today, technology has given us the ability to tap knowledge workers regardless of geographic locations, creating a global market for services writes […]
Interview: Ameera Shah, Owner & Managing Director, Metropolis Healthcare. Ameera set up Metropolis when she was just 20. Fourteen years on, the business is one of the big three labs in India. It is the only one of the big three to expand abroad with lab operations in seven countries across Africa, the Middle East and Sri Lanka. It carries out 15 million tests a year through 125 labs and 800 phlebotomy centres. Ameera is also speaking at our annual conference in London on April 28, 2015.
Just had a fascinating chat with Ameera Shah, who set up a lab chain, Metropolis Healthcare in India in 2002 when she was 20. Since then, she has grown it to one of the top three in the country and expanded into (wait for it) Kenya, South Africa, UAE, Nigeria, Ghana, Sri Lanka and Mauritius!
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
